CN202427047U - Implantable iodine-125 radioactive seed strip - Google Patents

Implantable iodine-125 radioactive seed strip Download PDF

Info

Publication number
CN202427047U
CN202427047U CN 201220007303 CN201220007303U CN202427047U CN 202427047 U CN202427047 U CN 202427047U CN 201220007303 CN201220007303 CN 201220007303 CN 201220007303 U CN201220007303 U CN 201220007303U CN 202427047 U CN202427047 U CN 202427047U
Authority
CN
China
Prior art keywords
iodine
radioactive seed
seed source
radioactive
medical catheter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201220007303
Other languages
Chinese (zh)
Inventor
颜志平
罗剑钧
王建华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongshan Hospital Fudan University
Original Assignee
Zhongshan Hospital Fudan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongshan Hospital Fudan University filed Critical Zhongshan Hospital Fudan University
Priority to CN 201220007303 priority Critical patent/CN202427047U/en
Application granted granted Critical
Publication of CN202427047U publication Critical patent/CN202427047U/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Radiation-Therapy Devices (AREA)

Abstract

The utility model provides an implantable iodine-125 radioactive seed strip which is characterized by comprising a medical catheter, wherein the two ends of the medical catheter are sealed, and iodine-125 radioactive seeds are placed inside the medical catheter. The iodine-125 radioactive seeds include a titanium shell and a silver rod which is arranged inside the titanium shell and absorbs iodine-125 radioactive nuclide on the surface. The implantable iodine-125 radioactive seed strip has less implanting damage, and can be implanted into a cavity only by one puncture.

Description

A kind of implantation property iodine-125 radioactive seed source bar
Technical field
This utility model relates to a kind of implantation property iodine-125 radioactive seed source bar, is used to treat malignant entity tumor, belongs to technical field of medical instruments.
Background technology
Implant iodine-125 radioactive seed source treatment malignant entity tumor technology between tissue and extensively carry out clinically, and obtained good curative effect.Implant the iodine-125 radioactive seed source between traditional tissue and have following shortcoming:
1, need multiple spot, repeatedly implant for reaching prescribed dose, penetration damage is bigger;
2, be difficult to guarantee that the iodine-125 radioactive seed source of being implanted is evenly distributed at the target intralesional;
3, the iodine-125 radioactive seed source of being implanted is shifted, and causes the radiation damage in non-focus zone.
Summary of the invention
The purpose of this utility model provides a kind of implantation property iodine-125 radioactive seed source bar, utilizes intracavity to implant the ionizing radiation that iodine-125 radioactive seed source bar is produced, and the pathological changes that causes portal vein, postcava and malignant biliary obstruction is carried out brachytherapy.
In order to achieve the above object, this utility model provides a kind of implantation property iodine-125 radioactive seed source bar, it is characterized in that, comprises medical catheter, described medical catheter closed at both ends, and inside is provided with the iodine-125 radioactive seed source.
The silver rod that described iodine-125 radioactive seed source comprises the titanium shell and is located at the surface adsorption iodine-125 radionuclide in the titanium shell.
Preferably, the length of the silver rod of described surface adsorption iodine-125 radionuclide is 3~4mm.
Preferably, the length of described titanium shell is that 4~5mm, diameter are 0.5~1mm.
The utility model has the advantages that:
1, the implantation damage is little, only needs one-time puncture can accomplish intracavity and implants iodine-125 radioactive seed source bar;
2, the radiation that the iodine-125 radioactive seed source of having guaranteed to implant is produced is evenly distributed at the target intralesional;
3, the iodine-125 radioactive seed source bar of being implanted is closed in the plastic catheter, and conduit is fixed on support again
And between portal vein, cavity of resorption or the biliary tract wall, thereby eliminated the displacement of iodine-125 radioactive seed source, and will descend greatly the radiation damage in non-focus zone;
4, utilize intracavity to implant the ionizing radiation that iodine-125 radioactive seed source bar is produced; The radiotherapy that the change disease that causes portal vein, postcava and malignant biliary obstruction is continued; Significant prolongation the unobstructed time of above-mentioned tube chamber, further reach the target that prolongs patient life cycle, improves the quality of living.
Description of drawings
Fig. 1 is the sketch map of iodine-125 radioactive seed source;
Fig. 2 is the sketch map of iodine-125 radioactive seed source bar.
The specific embodiment
Below in conjunction with accompanying drawing and embodiment this utility model is described further.
Embodiment
As shown in Figure 2, be the sketch map of iodine-125 radioactive seed source bar, described iodine-125 radioactive seed source bar comprises medical catheter 4, inside is provided with iodine-125 radioactive seed source 1.The external diameter of medical catheter 4 is that the internal diameter of 1.35mm, medical catheter 4 is 1.0mm, and iodine-125 radioactive seed source 1 is packed into behind the medical catheter 4, and two ends are sealed with flame, and forming length is the iodine-125 radioactive seed source bar of L, implants malignant tumor then and blocks the place.As shown in Figure 1, be the sketch map of iodine-125 radioactive seed source, the silver rod 2 that described iodine-125 radioactive seed source 1 comprises titanium shell 3 and is located at the surface adsorption iodine-125 radionuclide in the titanium shell 3.The length of the silver rod 2 of described surface adsorption iodine-125 radionuclide is 3.25mm.The length of described titanium shell 3 is that 4.5mm, diameter are 0.8mm.
During use; 2 grades of smooth branches of puncture liver inside door beniol under us guide; Row portal vein radiography; Measure the quantity that malignant tumor is blocked segment length, confirmed the iodine-125 radioactive seed source 1 of required implantation, iodine-125 radioactive seed source 1 is packed in aseptic, the transparent medical catheter 4, one-time puncture is accomplished intracavity and is implanted iodine-125 radioactive seed source bar.

Claims (4)

1. the property implanted an iodine-125 radioactive seed source bar is characterized in that, comprises medical catheter (4), described medical catheter (4) closed at both ends, and inside is provided with iodine-125 radioactive seed source (1).
2. implantation property iodine-125 radioactive seed source bar as claimed in claim 1; It is characterized in that the silver rod (2) that described iodine-125 radioactive seed source (1) comprises titanium shell (3) and is located at the surface adsorption iodine-125 radionuclide in the titanium shell (3).
3. implantation property iodine-125 radioactive seed source bar as claimed in claim 2 is characterized in that, the length of the silver rod (2) of described surface adsorption iodine-125 radionuclide is 3~4mm.
4. implantation property iodine-125 radioactive seed source bar as claimed in claim 2 is characterized in that, the length of described titanium shell (3) is that 4~5mm, diameter are 0.5~1mm.
CN 201220007303 2012-01-10 2012-01-10 Implantable iodine-125 radioactive seed strip Expired - Fee Related CN202427047U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201220007303 CN202427047U (en) 2012-01-10 2012-01-10 Implantable iodine-125 radioactive seed strip

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201220007303 CN202427047U (en) 2012-01-10 2012-01-10 Implantable iodine-125 radioactive seed strip

Publications (1)

Publication Number Publication Date
CN202427047U true CN202427047U (en) 2012-09-12

Family

ID=46776528

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201220007303 Expired - Fee Related CN202427047U (en) 2012-01-10 2012-01-10 Implantable iodine-125 radioactive seed strip

Country Status (1)

Country Link
CN (1) CN202427047U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112546462A (en) * 2020-12-28 2021-03-26 西安交通大学医学院第一附属医院 Magnetic dredging device for radioactive narrow biliary tract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112546462A (en) * 2020-12-28 2021-03-26 西安交通大学医学院第一附属医院 Magnetic dredging device for radioactive narrow biliary tract

Similar Documents

Publication Publication Date Title
US6709381B2 (en) Brachytherapy systems and methods
EP2070493A1 (en) Duct stent being capable of carrying the subminiature radioactive particle source
CN102125717B (en) Biliary tract internal drainage tube carrying radioactive particles
US20080249398A1 (en) Hybrid Source Containing Multi-Radionuclides for Use in Radiation Therapy
US20070265488A1 (en) After-loader for positioning implants for needle delivery in brachytherapy and other radiation therapy
US20080004483A1 (en) Biodegradable seed placement device and method
CN103877675A (en) Intracavity radioactive-particle implant
US20120108882A1 (en) Brachytherapy Devices and Related Methods Providing Bioaborbability and/or Asymmetric Irradiation
CN105407955B (en) The device and method for conveying drug
CN108525142A (en) A kind of I-125 seeds implanted device and apply its method for implantation
CN202427047U (en) Implantable iodine-125 radioactive seed strip
CN103830836A (en) Drainage catheter capable of carrying radioactive particles
WO2005023367A3 (en) X-ray and gamma ray emitting temporary high dose rate brachyterapy source
CN107569766A (en) A kind of radioactive particle support for cavity tumour Inner irradiation
Nap-van Klinken et al. Interstitial brachytherapy for bladder cancer with the aid of laparoscopy
CN208927418U (en) A kind of radioactive particle bracket for cavity tumour Inner irradiation
US8444544B1 (en) Device and method for intensity modulated brachytherapy
CN203710540U (en) Connecting chain capable of degrading radioactive sealing seed sources
CN203710541U (en) Intracavity radioactive particle implanting device
CN112451850B (en) Iodine-125 is implantation device for particle
CN201768261U (en) Degradable radioactive seeds source with chemotherapy function
CN203736702U (en) Drainage catheter capable of loading radioactive particles
CN201877140U (en) Sealed radioactive source for tumor implantation therapy
CN205145384U (en) Glioma postoperative radiation therapy's auxiliary device
CN209729528U (en) A kind of sealed radioactive source

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120912

Termination date: 20170110